Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Original Article
Author Details :
Volume : 5, Issue : 4, Year : 2018
Article Page : 191-194
https://doi.org/10.18231/2393-9087.2018.0039
Abstract
Introduction: Pain and inflammation are a day to day affliction for all living beings. Mankind has for years been trying to relieve the agony of pain & inflammation through various means with a large amount of success. Still we have not been able to produce the ideal analgesic or the ideal anti-inflammatory drug. The objective of this study was to evaluate a saponin, albichinoside, with respect to its ability to relieve pain and /or show anti-inflammatory activity.
Materials and Methods: The study was conducted on rats. The saponin was evaluated for its effects on acute, sub-acute, chronic and immunological inflammation by using standard anti-inflammatory study protocols.
Results: The test substance showed significant inhibition of acute, sub-acute and chronic inflammation produced by immunological and non-immunological methods in rats. These activities were qualitatively less as compared to indomethacin. This activity was like that of non-steroidal anti-inflammatory agents.
Conclusion: The test substance has moderate anti-inflammatory activity which could be by means of inhibition of prostaglandin synthesis and the complement.
Keywords: Saponin, Anti-inflammatory, Animals.
How to cite : Naresh N, Dinesh D , Sharma A, Anti-inflammatory studies on a saponin albichinoside. Indian J Pharm Pharmacol 2018;5(4):191-194
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.